News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘BreastCancer’ clear

  • In a nationwide study of women with triple-negative breast cancer, adding the chemotherapy drug carboplatin or the angiogenesis inhibitor Avastin to standard chemotherapy drugs brought a sharp increase in the number of patients whose tumors shrank away completely.

Tags: chemotherapy, BreastCancer

  • Combination of cell-killing drug and monoclonal antibody slowed or halted tumor growth in almost half a group of patients whose cancers had become resistant to standard treatments.

Tags: Antibody, BreastCancer

  • Elevated levels of anxiety may cause women with ductal carcinoma in situ (DCIS), the most common form of non-invasive breast cancer, to overestimate their risk of recurrence or dying from breast cancer, suggests a study led by Dana-Farber researchers.

Tags: BreastCancer

  • The American Society of Clinical Oncology (ASCO) today issued a new clinical practice guideline on chemotherapy and targeted therapy for women with HER2-negative advanced breast cancer. The guideline provides detailed, evidenced-based information on the efficacy and side effects of various therapies.

Tags: BreastCancer

  • Black and Hispanic women are less likely than white women to receive the radiation therapy routinely prescribed following surgery for early breast cancer, according to a study by Dana-Farber researchers.

Tags: BreastCancer, Disparities

  • Dana-Farber researchers have demonstrated a molecular strategy that they say could make a much larger variety of tumors treatable with PARP inhibitors, a promising new class of cancer drugs.

Tags: BreastCancer, OvarianCancer, GynecologicCancers

  • Results of the study show greater efforts are needed to ensure that all women receive the most effective breast cancer care, regardless of their race or ethnicity.

Tags: BreastCancer, Disparities

  • In one of the largest breast cancer sequencing efforts to date, scientists from Dana-Farber and their colleagues have discovered surprising alterations in genes that were not previously associated with breast cancer.

Tags: BasicResearch, BreastCancer, Genomics

  • The committee will help the CDC develop evidence-based approaches to advance the understanding and awareness of breast cancer among young women.

Tags: BreastCancer

  • The Centers for Disease Control and Prevention’s (CDC) Division of Cancer Prevention and Control (DCPC) has awarded a $1.75 million 5 year grant to the Program for Young Women with Breast Cancer at Dana-Farber Cancer Institute to increase the awareness of breast cancer among women and enhance the support services for those diagnosed and treated. The Program for Young Women with Breast Cancer at Dana-Farber was one of only seven organizations to be awarded this competitive grant.

Tags: BreastCancer, Grants

Showing 1-10 of 48 items